12 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
American Association of Critical-Care Nurses Grants Program
AACN enthusiastically supports members of our community who seek evidence to support our bedside colleagues in ensuring safety and excellent care for patients and their families. Funds from AACN in collaboration with professional associations and industry continue to increase support for research that drives change in high acuity and critical care nursing practice.
As part of our grants program, up to nine grants are awarded annually, with awards ranging from $1,500 to $50,000. Applications are accepted annually starting September 1 with a submission deadline of November 1.
Please apply only for the grant that most closely matches your topic. Grants offered are:
AACN Impact Research Grant Research addressing AACN Research Priorities. Two awards up to $50,000 each.
AACN-Edwards Lifesciences Nurse-driven Clinical Practice Outcomes Grant Research studies focusing on protocol-based care. Award up to $10,000.
AACN-Sigma Theta Tau Critical Care Grant Available to AACN and Sigma Theta Tau members. Award up to $10,000.
AACN-Philips Medical Systems Clinical Outcomes Grant Research on improved outcomes and system efficiencies. Three awards up to $10,000 each.
AACN Physio-Control Clinical Practice Grant Acute myocardial infarction, resuscitation or sudden cardiac death. Award up to $1,500.
American Association of Critical-Care Nurses 101 Columbia Aliso Viejo, CA 92656-4109
AACN Website http://www.aacn.org AACN E-mail info@aacn.org
Call for Applications: American Academy for Cerebral Palsy and Developmental Medicine Research Grant Award
Deadline: Monday, April 2, 2012
A key mission of the Academy is to promote excellence in research for the benefit of persons with cerebral palsy and childhood-onset disabilities. One way in which the Academy promotes research is through the annual AACPDM Research Grant.
The AACPDM Research Grant Award provides seed funding to develop a high quality clinical research project/program. The award is expected to produce a competitive interdisciplinary, multi-investigator/center grant proposal for submission to larger agencies/funders of research in any area relevant to the AACPDM. Any member of the AACPDM is eligible to apply. Only one grant application per member will be considered in a given budget year. The budget limit is US $25,000 (subject to approval by the Board, which reserves the right to amend the amount awarded).
Successful applicants are expected to take up the award within one month of the annual AACPDM meeting where the award is announced. The funds must be spent within 18 months. Applicants unable to meet this timeframe will forfeit the grant but will be eligible to re-apply in a subsequent year. Unspent funds after 18 months are expected to be returned to the AACPDM.
Use of Funds The award may be used to fund any of the elements necessary to develop the full grant proposal. These may include costs for:
Teleconferences or meetings of the collaborating team of investigators to plan and develop the research protocol including study design, outcome measures, recruitment strategies, data collection and management, analysis, etc Methodologic/Statistical support or consultation Preparation of application/s for institutional ethics approval Support for investigators time Pilot project/feasibility study in preparation for multi-center project Validation of outcome measures intended for multi-center project
The funds are not intended for:
Institutional indirect costs Purchase of personal computers or equipment Stipends or fees for students or post doctoral fellows
AACPDM Office 555 East Wells, Suite 1100 Milwaukee, WI 53202 Phone: 414.918.3014 Fax: 414.276.2146 Email: info@aacpdm.org URL: www.aacpdm.org Office Hours: 8:00 am - 5:00 pm CST
Call for Applications: Orthopaedic Research and Education Foundation Prospective Clinical Research Grant in Spine Care
Applications due March 8, 2012
Spine surgeons who are board-certified in neurosurgery and/or orthopaedic surgery are invited to apply for up to $300,000 ($50,000-$100,000 per year for up to three years) in grant support to further the work of individual investigators, investigator networks, single institutions, or consortia of institutions conducting prospective clinical research. Grants will in spine care in any of the following study areas:
spinal deformity—adult deformity outcomes, spondylolisthesis, pediatric scoliosis, pediatric kyphosis, and early onset scoliosis; spine trauma—epidemiology, process and outcomes of spinal injuries, surgical treatment of acute spinal cord injury); degenerative spinal disorders—prospective outcomes for surgical and non-surgical treatments of lumbar, cervical, and thoracic degenerative spinal disorders; spinal oncology (epidemiology, process and outcomes of primary and metastatic spinal tumors);and non-surgical interventions for the treatment of spine injuries and disorders, including diagnostic, public health and rehabilitative methodologies.
Grants will be awarded to qualified recipients based on satisfaction of published eligibility and application requirements, and independent peer review. Peer review teams of spine surgeons and spine care investigators will be assembled by OREF and directed by OREF’s Advisory Committee on Clinical Research in Spine Care in accordance with OREF peer review standards and procedures, comprising neurosurgeons and orthopaedic surgeons who are appointed solely by OREF. Completed applications are due to OREF by March 8, 2012, funding to begin May 1, 2012.
These grants are made possible by support from Medtronic Sofamor Danek, USA, Inc. As is the case for all OREF donors, Medtronic has no influence on disbursement or management of funds; the composition OREF staff or its board or committees; content of program communications; any aspect of grant administration, application review or selection of funded proposals/recipients; conduct of program activities; or dissemination of findings from funded projects.
For more information please contact:
Jean McGuire, V.P., Grants (847) 384-4348 Mary Marino, Grants Administrator (847) 384-4359
Damon Runyon Clinical Investigator Award
Application deadline date for this award: February 15, 2012
The Damon Runyon Clinical Investigator Award supports young physician-scientists conducting patient-oriented cancer research. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
The Clinical Investigator Award responds to three recognized realities:
Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year. The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low. The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
Building on the long-term success of the Damon Runyon Postdoctoral Fellowships, the creation of the Clinical Investigator Award is a logical extension of the Foundation’s overall mission to defeat cancer. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators.
Definition of Clinical Research
For the purposes of this award, the Foundation’s definition of clinical research will follow the definition set out in “The NIH Director’s Panel on Clinical Research Report to The Advisory Committee to The NIH Director,” December, 1997.
a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers. b) Epidemiologic and behavioral studies. c) Outcomes research and health services research.
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.
Partnership with NIH and NCI
Damon Runyon has a novel partnership with the National Institutes of Health (NIH) and the National Cancer Institute (NCI), which uniquely opens access to the NIH Clinical Center (CC) to Damon Runyon Clinical Investigators. The goal of this partnership is to use the special talent, expertise and resources of the participants to undertake pilot studies of specific diseases and to develop collaborative partnerships that accelerate clinical and translational cancer research, and thereby improve human health.
Potential opportunities for pilot partnership:
1. Damon Runyon Clinical Investigator Award applicants may apply with a mentor or co-mentor from NCI or another NIH Institute. The proposal must identify the research to be done at and resources to be used at the NIH CC.
2. Current Damon Runyon Clinical Investigators may conduct a research project at the NIH CC in collaboration with an NIH tenured/tenure-track investigator. The Damon Runyon Clinical Investigator would be the PI or co-PI on the project.
3. Current Damon Runyon Clinical Investigators may request to use the special equipment or facilities at the NIH CC, which could provide opportunities for investigators that may not be possible in their home institutions. Examples are: obtaining research materials such as research PET ligands or products from the CC Good Manufacturing Practice (GMP) facilities, or accessing other non patient-related activities/facilities. No NIH scientist collaboration would be required.
Please contact the Foundation’s Chief Scientific Officer, Yung Lie, with any questions regarding NIH/NCI partnership opportunities (212.455.0521).
Research, Training and Development
During each year of the award, the applicant must commit a minimum of 80% of their full-time professional effort to the conduct of research and research career development.
The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of human disease-oriented clinical and translational research. The Mentor also acts as an advocate for the applicant at the departmental, institutional, and professional levels. Selection and Review
The Clinical Investigator Award Committee (CIAC) will review applications and select awardees for approval by the Damon Runyon Cancer Research Foundation's Board of Directors. CIAC puts a premium on innovation and creativity when reviewing applications.
Selection Criteria
Excellence of the applicant and mentor. Innovation, creativity, quality and originality of the research proposal. The commitment of the mentor and institution to the development and training of the applicant as a skilled clinical research investigator. Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems. Importance of the proposed research to the field of cancer and/or cancer prevention. Adherence of the proposal to the definition of clinical research as set out on this web page. Adherence to the “Handshake Rule.”
Program Sponsors
Under the leadership of the Damon Runyon Cancer Research Foundation, the Clinical Investigator Award is funded in part through Accelerating Cancer Cures, a collaboration of the biopharmaceutical industry, academia and young researchers formed to achieve breakthroughs against cancer by rebuilding the ranks of brilliant and committed clinical investigators who can translate science into cures. Members include: Eli Lilly and Company, Celgene, Merck, Millennium: The Takeda Oncology Company, Pfizer and The Pharmaceutical Research and Manufacturers of America (PhRMA).
Eligibility
The applicant must be a U.S. citizen or permanent legal resident. Each applicant must be nominated by his/her institution. Applications will only be accepted from institutions that have been invited to submit them by the Foundation http://www.damonrunyon.org/for_scientists/more/invited_institutions/
Three (3) nominations per institution, including its affiliated schools, will be accepted. Because of its number of affiliated hospitals, Harvard Medical School may submit up to six (6) nominations.
The applicant must have received an MD or MD/PhD degree(s) from an accredited institution and be board-eligible.
The applicant may apply within the first four (4) years of his/her initial full faculty appointment after the final year of his/her subspecialty training (Adjunct or acting positions are not eligible).
Candidates may apply up to three times during this eligibility period. Candidates holding or awarded R01s at the time of application are not eligible to apply.
The applicant must commit to spending 80% of their time conducting research.
The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
Funding
The $450,000 award will be for a period of three years. Funding in the amount of $150,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs including the Investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research. No part of this grant can be used for indirect costs or institutional overhead.
Other Funding
Investigators may receive funding from other sources to support their research. However, no other physician-scientist career development award from a private source (non-federal government) may be held concurrently with the Clinical Investigator Award.
Physician-scientist career development awards from the federal government including the National Institutes of Health (e.g., K-08, K-12, K-23), the Department of Defense, and the U.S. Department of Veterans Affairs are allowed.
Scientific or budgetary overlap with other funded projects is not allowed. Therefore, it is critical that all current and pending grant support for your research be reported to the Foundation and the relationship of that support to the Damon Runyon funded project be explained.
Examples of awards that cannot be held concurrently with the Damon Runyon Clinical Investigator Award include (but are not limited to):
AACR- Career Development Award American Cancer Society- Mentored Research Scholar Grants in Applied and Clinical Research ASCO- Career Development Award Burroughs Wellcome Fund- Career Award for Medical Scientists Doris Duke Charitable Foundation- Clinical Scientist Development Award Howard Hughes Medical Institute- Physician-Scientists Early Career Award, Early Career Scientist Competition Kimmel Foundation- Kimmel Translation Science Award, Kimmel Scholar Award Leukemia and Lymphoma Society- Career Development Program, Scholar Awards
Please contact the Foundation with any questions regarding concurrent funding (212.455.0520). Debt Repayment Program
The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee.
Contact Information: Award Programs | 212.455.0520 | awards@damonrunyon.org
American Orthopaedic Society for Sports Medicine/Smith & Nephew Innovative Outcomes Assessment Grant
AOSSM is pleased to announce a new grant sponsored by Smith & Nephew to support development of innovative approaches to measuring the effects of surgical procedures in orthopaedic sports medicine. This $25,000 grant is meant to advance the evaluation of clinical outcomes related to surgery by encouraging development of novel approaches, techniques, and/or methodology that will facilitate and enhance clinical research. Examples might include new web-based instruments to allow inter-institutional collaborative efforts, tools to quantify joint laxity, or innovative methods to measure the results of arthroscopic procedures about the hip. The intent of this award is to provide start-up funding for the development of tools and/or technology that can be leveraged and used for future, larger-scale clinical research studies.
Applications for this grant will be judged on three criteria:
• Innovation • Feasibility • Clinical Significance
The proposal should define the limitations with currently available assessments, clearly describe the proposed innovative approach, state how the new assessment will be tested, and discuss the clinical significance of this novel method to the field if successful. Because this grant is intended to foster new ideas and creativity, prior data related to the innovation is not required but can be presented to establish feasibility. Deadline for applications is April 17, 2012. The principal investigator or a co-investigator must be an AOSSM member in good standing.
All information should be submitted in one pdf document to Bart Mann, AOSSM Director of Research.
AOSSM gratefully acknowledges Smith & Nephew for the educational grant to support this activity.
American Orthopaedic Society for Sports Medicine 6300 N River Road Suite 500 Rosemont, IL 60018 847/292-4900 847/292-4905 fax 877/321-3500
American Association of Endodontists Foundation Research Grant Program
Research grants are awarded twice a year. To date, over $2.1 million has been awarded to researchers. Grants are reviewed and evaluated by the AAE Research and Scientific Affairs Committee. Grant recipients are notified after Annual Session for the spring cycle and after the Foundation Board of Trustees Interim Meeting for the fall cycle. Per review cycle, the highest scoring student and nonstudent research proposals receive special recognition and an additional $500 award.
Spring/Summer Application Deadline February 7, 2012 Fall/Winter Application Deadline August 18, 2011
The AAE Foundation will offer additional awards of $500 to the top rated student and non-student proposals.
Grant Application Policies 1. Submissions will not be accepted after 5 p.m. Central Standard Time on the day of the deadline. Applicants are notified that their proposal was received and deemed complete within one week of the deadline. Funding is announced in November and in June.
2. Submissions must strictly follow the guidelines. Incomplete and/or submissions that deviate from the guidelines will be disqualified and not considered for funding.
3. No dollar limits are set for grants. Funds awarded are made payable to the principal investigator and his/her institution. Unused funds must be returned to the AAE Foundation within 60 days of completing the grant.
4. The Foundation does not support indirect costs to a recipient’s institution. All funds must be spent in support of the proposed investigation and within the funding period of the grant.
5. A progress report must be submitted within 30 days of the project’s completion. An abstract of the results must also be submitted within six months after completion of the project. An expense account itemizing the use of funds must also be included. The failure of a grantee to submit a final project report will make his/her school ineligible for funding for one year. All grant recipients are highly encouraged to present their research at the AAE Annual Session within one year of the project’s completion.
6. Applicants who are submitting a revised proposal should write an introduction in which they respond to the Research and Scientific Affairs Committee’s critique of their original proposal on a point-by-point basis. Wherever possible, applicants should indicate changes by striking out previous language and highlighting inserts. Proposals not approved for funding may be resubmitted once for reconsideration and review.
7. New submissions from previous grantees must include evidence that the results of the most recently funded project have been published, are in press or have been submitted for publication. A letter from the editor of a refereed journal acknowledging that a manuscript was submitted will meet this requirement. Former grantees who do not include this material with their new application will be disqualified.
8. Manuscripts based on research supported by the AAE Foundation must be submitted first to the Journal of Endodontics. The following statement must be included in any written or oral presentation of research supported by the AAE Foundation:
This research was supported in part by a Research Grant from the American Association of Endodontists Foundation. Follow-up reports on completed research projects must include a copy of the submission form to the JOE. Failure to comply will jeopardize the opportunity for future funding and publication in the Journal of Endodontics.
Purpose and Priorities The AAE Foundation inspires and supports research and the genesis of new knowledge in endodontics. To make the best use of funds, the AAE has identified research priorities. Where two proposals are judged equal, the one that addresses the AAE priorities will be given preference. Proposals with budgets over $25,000 must directly address a priority.
Eligibility Researchers who meet the following criteria are eligible: students of an advanced specialty education program in endodontics at a dental school that is accredited by or has a reciprocal agreement with the Commission on Dental Accreditation of the American Dental Association; faculty or researchers in endodontology or related fields (microbiology, pathology, physiology) of a dental school that is accredited by or has a reciprocal agreement with the Commission on Dental Accreditation of the ADA; active members of the AAE. Dental school faculty or research staff who are not endodontists are strongly encouraged to include an endodontist as consultant or co-investigator. To encourage international scientific exploration, an international researcher may be included as a collaborator on projects that are carried out at institutions that are accredited by or have a reciprocal agreement with the Commission on Dental Accreditation of the American Dental Association. Travel expenses may be included in the request for funding as part of the itemized budget.
Postgraduate Students Postgraduate students must be AAE members. Priority will be given to students in the first year of a two-year endodontic program or the first or second year of a three-year program. The student should decide on a research project early in his/her training so that it may be completed by graduation.
Review Process Applications are reviewed by the AAE Research and Scientific Affairs Committee. Each protocol is evaluated in competition with all others. The committee submits recommendations to the Board of Trustees of the AAE Foundation. The Trustees allocate and award funds. Committee members who have a vested interest in a project or an institution are excluded from evaluating that grant application. When necessary, the committee obtains evaluations from outside reviewers.
Applications are evaluated based on the following criteria:
A. Significance of research and its relation to the AAE Research Priorities B. Scientific merit and potential for discovering new information C. Excellence of research design and statistical methods and probability of successful completion D. Extent to which the project has been previously funded E. Extent to which alternative funding sources were sought F. Extent to which the research can lead to future innovations in clinical endodontics, or future research that is funded by national or federal funding agencies
All applicants will receive a critique of their proposal. For further information, call the Development Coordinator of the AAE Foundation at 312/266-7255, ext. 3008.
AAE Research Priorities Research
The AAE accepts proposals in the following areas of investigation. Systematic reviews of topics related to the priority list will be considered along with other types of research.
A. Assessment of Clinical Outcomes 1. Factors affecting success of endodontic treatment a. Nonsurgical and surgical endodontic treatment b. Effect of number of visits c. Effect of instrumentation and obturation techniques d. Timeliness and quality of the coronal restoration e. Effect of the dental operating microscope on the success of nonsurgical retreatment and surgical endodontic treatment f. Effect of residual microorganisms following instrumentation and/or medication
2. Management of anxiety, infection, inflammation and pain
3. Long-term cost effectiveness of endodontic treatment compared to treatment alternatives
B. Assessment of New Technology Such as Devices and Materials
C. Biology of Pulpal and Periradicular Tissues 1. Focal infection (relationship, if any, of endodontic treatment to systemic diseases) a. Fate of remaining microorganisms in endodontically treated teeth and the supporting periodontium b. Effects of acute and chronic periradicular infections and their management on systemic health c. Epidemiological relationship between endodontic treatment and systemic diseases d. Pathogenesis and healing of endodontic infections in patients with chronic systemic diseases
2. Development of sophisticated methods of diagnosis including enhanced imaging of teeth and periradicular tissues
3. Identification, clarification and use of neurotransmitters, growth factors, genetic or genomic factors, and other biologic regulators to manage endodontic disease
4. Effect of endodontic materials on local tissue response and systemic health
5. Contribution of microorganisms to the pathogenesis of pulpal and periradicular disease
D. Cracks and Fractures in Teeth
1. Diagnosis of cracked teeth
2. Management of cracked teeth and repair of root fractures
3. Investigation of treatment modalities for vital teeth and endodontically treated teeth
4. Development of in vitro and in vivo model systems to evaluate materials, techniques, and assessment of clinical outcomes
5. Epidemiology of cracked teeth and endodontic sequelae
E. Demographics/Epidemiology of Pulpal and Periradicular Disease
1. Prevalence of pulpal and periradicular disease and projections
2. Current and projected demand for endodontic services
3. Current and projected status of the endodontic practice
F. Endodontic/Implant Relationships
1. Relationship between endodontically treated teeth and adjacent implant(s)
2. Assessment of clinical outcomes of implants vs. endodontically treated teeth
G. External and Internal Resorption
1. Etiology and biology of root resorption
2. Effective treatment modalities with assessment of clinical outcomes
H. Educational Research
1. Current and projected status of endodontic education
2. Development and assessment of creative models and application of these models in graduate student, dental student and continuing education programs
3. Design of innovative programs that would use technology to improve the quality and efficiency of graduate student, dental student and continuing education programs
4. Development of a telecommunication system, “teledentistry,” to enhance continuing education and consultations
I. Tissue Engineering—Regeneration of the Pulpodentin Complex and Periradicular Tissues
1. Optimal scaffold materials and signaling molecules needed to regenerate the pulp-dentin complex and periradicular tissues
2. Source of cells needed to regenerate pulp-dentin complex and periradicular tissues
3. Molecular processes that control stem cell activity within the pulp-dentin complex
4. The fate of the stem cells within the pulp-dentin and periradicular tissues
5. Advantages and disadvantages of different sources of cells to regenerate the pulp-dentin complex and periradicular tissues
6. Animal models that can be used to replicate disease conditions and test hypotheses related to regenerating the pulp-dentin complex and periradicular tissues
7. The influence of enhanced methods of disinfecting and shaping the root and root canal system on regenerative procedures
8. Identification of desirable/undesirable outcomes of regenerative procedures
9. Identification of appropriate outcome measures of regenerative endodontic procedures for example; in vivo imagining, laser Doppler flowmetry, micro CT, etc.
10. Patient and clinical factors affecting the outcomes of regenerative endodontic procedures
American Association of Endodontists Foundation 211 E. Chicago Ave., Suite 1100 Chicago, IL 60611-2691 Phone: 800/872-3636 (North America) or 312/266-7255 (International) Fax: 866/451-9020 (North America) or 312/266-9867 (International) E-mail: foundation@aae.org
International Spine Intervention Society Research Grant Program
The International Spine Intervention Society (ISIS) is dedicated to the advancement of the science of interventional spine care through its support of research efforts.
General Information:
ISIS Membership is a requirement for a research grant Multiple grants may be granted per year Research Proposal must be original research that is to be preformed, not work that is already completed Institutional Review Board approval is mandatory when the study involves human or animal subjects
The Research Grant Application should consist of a proposal with the following elements:
Summary of the project Significance of this research in the advancement to understanding in the field Objectives Hypothesis Background information and research proposal justification Research design and methods Facilities available to make this study possible Budget: total and per year Signed Institution Release of Overhead and Indirect Costs
The Research Grant Application should also include:
Curriculum Vitae for each investigator Investigational Review Board materials Consent form Outcome tools
Deadlines Funding of Research Proposal is approved at the bi-annual ISIS Board of Directors meetings and must be submitted by: May 1st or November 1st
Institutional Overhead ISIS does not pay institutional overhead or indirect costs associated with its grants. Applications are to be reviewed and approved by the applicant’s institution prior to submission.
Selection Process Research grant applications will be reviewed by the ISIS Research Committee using a 100 point scoring system. Proposals are evaluated on scientific merit (10 points), significance (15 points), originality (10 points), methodology (40 points), abstract and background information (10 points), personal and institutional track record (5 points), and feasibility (10 points). Overall evaluation of the application from the perspectives of its level of evidence, relevance to the membership and our patients, potential impact on the related science, clinical decision making and health care policy, and value in terms of impact to budget ratio, will also be considered.
If a research grant application is submitted by an ISIS Research Committee member then he/she is excluded from its review process.
Presentation Once the study is completed and the final results are analyzed, it must be presented at the next ISIS Annual Scientific Meeting. It is also expected that the results be published in a peer-reviewed journal.
Citation ISIS must be cited as the source of funding in all publications and presentations from the project or its results. A copy of all publications and presentations must be sent to the ISIS office.
Research Reports Investigators are required to submit bi-annual research update forms and final research findings to the Research Committee Chair and Association Coordinator. If an investigator fails to do so they will be denied any future funding and requested to return all funds distributed to them.
Questions Please contact the ISIS office with questions at 415.457.4747 or email grants@spinalinjection.org
Call for Applications: National Spasmodic Dysphonia Association Research Grant Program
The National Spasmodic Dysphonia Association is seeking research applications for new investigator startup grants or post doctoral study focused on research aimed at increasing understanding of spasmodic dysphonia.
Small seed money grants to new or established investigators for up to $20,000 (excluding indirect costs) per year will be awarded. These can be for startup grants enabling successful applicants to subsequently seek funding from the National Institutes of Health or may provide partial support for post doctoral research training relating to spasmodic dysphonia.
We are interested in hypothesis-driven research related to new approaches aimed at increasing understanding of Spasmodic Dysphonia that focuses on the following areas:
Endogenous and environmental risk factors for the development of Spasmodic Dysphonia Pathophysiology of central nervous system dysfunction in Spasmodic Dysphonia Animal models for Spasmodic Dysphonia Novel approaches to the treatment of Spasmodic Dysphonia Diagnostic tools for Spasmodic Dysphonia Controlled studies of treatment outcomes in Spasmodic Dysphonia
The deadline to submit an application is March 1 each year.
National Spasmodic Dysphonia Association 300 Park Boulevard Suite 415 Itasca, IL 60143 Phone: 800-795-6732 Fax: 630-250-4505 NSDA@dysphonia.org
PhRMA Foundation Health Outcomes Sabbatical Fellowship
The PhRMA Foundation Sabbatical Fellowship in Health Outcomes provides stipend support for individuals engaged in a multidisciplinary research training program that will create or extend their credentials in health outcomes. The purpose (intent) of this program is to enable faculty with active research programs to work outside of their home institution for periods of 6 months to one year to learn new skills or develop new collaborations that will enhance their research and research training capabilities in health outcomes.
The applicant and mentor of the program must describe how the multidisciplinary goals of the research experiential program will be accomplished and provide assurance that key collaborating mentors endorse and are willing to support the plan.
Matching funds must be provided by the home institution.
Eligible applicants must (1) hold a PhD, Pharm.D., M.D. or Sc.D. degree in a field of study logically or functionally related to the proposed post doctoral activities, (2) hold a faculty appointment that imparts eligibility for a sabbatical leave from their home institution, (3) have institutional approval of a sabbatical plan that includes partial salary that matches the PhRMA stipend, (4) hold an endorsement from a mentor who agrees to sponsor the applicant's visiting scientist activity, and (5) be a U.S. citizen or permanent resident. Applications are to be submitted via the Foundation website and received by February 1, 2012. Applications will not be accepted after the deadline date.
Award
Provides up to $40,000 stipend support for mid-career scientists to engage in an academic year or calendar year experiential program intended to redirect their core research focus to an area of emerging importance to pharmaceutical research and development. The program provides no other subsidies (travel, tuition, fringe benefit costs, etc.) and indirect costs to the institution are not provided. It is expected that the fellowship will be administered in accordance with the prevailing policies and procedures of the institution. Successful applicants will have approval for a sabbatical leave from their home institution, and a commitment to host their experience from a research mentor in an environment other than the applicant's home institution. These funds are not transferable.
NOTE: Awards may be activated beginning July 1, 2012 or on the first day of any month thereafter, up to and including December 1, 2012.
PhRMA Foundation 950 F Street, N.W. Suite 300 Washington, DC 20004 USA
202-572-7756 phone 202-572-7799 fax
Call for Nominations: International Association for Dental Research Colgate Oral Health Research Award
Nomination Deadline: April 15, 2012
The Oral Health Research Group of the IADR is inviting nominations for a group-sponsored award in oral health research. The purpose of the award is to recognize a body of meritorious research by a member of the IADR Oral Health Research Group, with preference given to a Dental Hygienist.
Eligibility:
1. Nominee must be a member of the IADR Oral Health Research Group and, if a Dental Hygienist, a graduate of an accredited dental hygiene program. 2. Nominations must include a Curriculum Vitae that provides supporting evidence that the nominee has conducted original research. 3. A letter of nomination should highlight the major reasons and body of research for which the individual is being nominated. Work considered for this award should have resulted in publications in scientific, peer-reviewed journals.
Research Topic: Submissions must represent original research in the area of oral health. This includes a broad array of basic, clinical and applied studies related to: strategies for the prevention of oral disease and promotion of wellness; outcomes of primary and secondary preventive care; interdisciplinary approaches to integrating oral health into general health; clinical efficacy of professional and personal oral hygiene measures; methods to improve health outcomes of compromised patients; the dental hygiene process of care; self-care strategies; disease-prevention/health promotion focused curricular models; science transfer methods; ethics and quality assurance; alternative patterns for practice; clinical decision-making; and issues related to the conduct of research.
Award: A Certificate of Recognition and one cash award in the amount of $2,000 will be made. This award is intended to provide travel and other support related to attending the IADR annual meeting and participating in the Oral Health Research Group activities. Information about the award winner will be made available to dental hygiene and other dental publications.
Selection: A committee with an appointed chair or co-chairs, the President and Immediate Past-president of the Group will select the winner. A representative of Colgate-Palmolive Company will review eligibility qualifications with the committee. The award recipient will be formally announced during the business meeting of the Oral Health Research Group at the 2012 90th General Session & Exhibition of the IADR and honored during the reception that follows. Researchers who are currently under contract with Colgate-Palmolive are not eligible to participate. The committee may elect not to present an award if there is not an appropriate nominee.
Sponsorship: The Award is sponsored by a generous donation from the Colgate-Palmolive Company.
Nomination Deadline:
Nominations must be received by April 15, 2012.
Submit nominations electronically to Award Chair. Frances Doherty Genco, Award Chair Email: fgenco@gmail.com
12next
